Skip to main content
TEDCO’s new website is here!

We appreciate your patience as we continue to refine the site to provide the best possible experience for our visitors.

In The News

Displaying 521 - 540 of 1436
Filters
Type
by Theme

TEDCO, Maryland’s economic engine for technology companies, Tuesday announced an investment of $1 million in Cerebro Capital Inc. through its State Small Business Credit Initiative (SSBCI).

default

TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 State Small Business Credit Initiative (SSBCI) investment into KaloCyte, Inc.

default

Aidar Health snares TEDCO grant By Mark R. Smith Senior Writer The first two sentences on Aidar Health's website get to the point about its health checking device, MouthLab: "Creating a new paradigm for personalized care at home. Reimagjning today's 

default

Jesse Christopher, CEO of Longeviti Neuro Solutions joined Good Morning Washington to discuss the innovative solutions for complex brain surgery that Longeviti has pioneered, with help from TEDCO, a Maryland based venture capital leader.

default

TEDCO, Maryland’s economic engine for technology companies, announced a Seed Funds investment of $250,000 into Astek Diagnostics, a life sciences company fighting antibiotic resistance through innovative technology.

default

TEDCO, Maryland’s economic engine for technology companies, announced the successful exit of its portfolio company, Blackpoint Cyber, an Ellicott City, Md.-based, technology-focused cybersecurity company providing its security ecosystem via managed service pr

default

Elizabeth P. Clayborne, MD, MA Bioethics CEO/Founder, NasaClip Adjunct Assistant Professor of Emergency Medicine, University of Maryland School of Medicine Dr. Elizabeth Clayborne is a doctor, a mother, a CEO, a leader and a woman of color.

default

Theodore “Teddy” Gresser is TEDCO’s new Director, Seed Funds. Teddy began with TEDCO as part of the Venture Fellows program; afterwards, he joined the TEDCO team full-time as an Investment Analyst where his diligence and experience led him to his most recent promotion.

default

Jim Buck, President, CEO & Director, leveraging 30 years of experience successfully developing and commercializing innovative medical technologies.

default